Price T Rowe Associates Inc Vista Gen Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.09 - $0.16 $1,440 - $2,560	16,005 Added 89.14%	33,959 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.07 $9,996 - $76,398	-71,400 Reduced 79.91%	17,954 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $865 - $1,700	983 Added 1.11%	89,354 $79,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $4,560 - $8,360	4,000 Added 4.74%	88,371 $110,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $47,595 - $78,660	28,500 Added 51.01%	84,371 $165,000

Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $2,358 - $3,105	-900 Reduced 1.59%	55,871 $153,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $33,851 - $54,403	17,271 Added 43.72%	56,771 $179,000
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $74,655 - $116,920	39,500 New	39,500 $84,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.